Long-term therapy with itolizumab is safe and effective for patients with moderate to severe psoriasis: Results from an expanded-access program
-
Published:2024-06
Issue:
Volume:134
Page:112225
-
ISSN:1567-5769
-
Container-title:International Immunopharmacology
-
language:en
-
Short-container-title:International Immunopharmacology
Author:
Falcón Lincheta Leopoldina,
Saumell Nápoles Yaimarelis,
Gray Lovio Olaine R.,
Viqueira Fuentesfría Alina M.,
Pérez Alonso Teresita,
Batista Romagoza Maritza,
Urquiza Rodríguez Aleida,
Mantecón Fernández Beatriz,
Bautista Jerez Heber A.,
Fernández de Armas Damarys,
Martínez Matute Eldenida S.,
León García Yakelin,
Oramas Fernández Diana K.,
Marrero Chavez Yaneisy,
Fernandez Lorente Aymara,
Valls Hung Ana R.,
Lorenzo-Luaces PatriciaORCID,
Valenzuela Silva Carmen,
Moreno ErnestoORCID,
Hernández-Casaña PatriciaORCID